In breast cancer, PHF6 recruits the chromatin-remodeling factor BPTF for epigenetic modifications, thereby enhancing the transcriptional activity of the HIF pathway, which in turn promotes tumor angiogenesis and metabolic reprogramming [21]. This evidence concerns the gene BPTF and neoplasm.